Controlled Trials of Amphotericin B Lipid Complex and Other Lipid-Associated Formulations
Author(s) -
D. J. Winston,
Gary J. Schiller
Publication year - 2000
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/313579
Subject(s) - medicine , amphotericin b , lipid profile , pharmacology , cholesterol , antifungal , dermatology
are indicated to determine the true incidence of melioidosis in Central America, South America, and the Caribbean. Finally, I must correct some factual inaccuracies. First, the patient originally described by Whitmore and Krishnaswami [7] was 40 years old, not 10 years old as stated by Dorman et al. [1]. Second, the longest incubation period for melioidosis has recently been increased to 29 years [8]. Last, the case reported by Lee et al. [2] is not, as they state, the first reported case of mycotic aneurysm caused by B. pseudomallei; an earlier case was reported in 1996 [9].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom